Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Product Categories
(Total 12 Products for Egfr Mutant Inhibitors Mereletinib Mesylate 1421373 66 1)
Potent HER1/EGFR Inhibitor Erlotinib Hydrochloride CAS 183321-69-9
Erlotinib Hydrochloride CAS 183321-69-9, also called Erlotinib HCl, is a selective epidermal factor receptor (EGFR)-tyrosine kinase inhibitor and widely used to anti-neoplastic. Processed Erlotinib Hydrochloride CAS NO 183321-69-9 use superior quality raw material and cutting edge equipment to ensure its high purity...
High Purity PD 153035 Hydrochloride CAS 183322-45-4 for Sale
PD 153035 Hydrochloride CAS 183322-45-4, also called SU-5271, AG1517 and ZM252868HCl is yellow solid with the purity by HPLC more than 99%. PD 153035 Hydrochloride CAS NO 183322-45-4 is a potent inhibitor of EGFR (epidermal growth factor receptor) tyrosine kinase (IC50 = 25 pM), which soluble in DMSO (10 mM) with...
2-Amino-4-Methoxy-5-(3-Morpholinopropoxy)benzonitrile CAS 675126-27-9 is a primary intermediate for synthesis Gefitinib. Gefitinib is a potent EGFR inhibitor used for certain breast, lung and other cancers. We have engaged in this industry for many years who are rich experience in export. Depend on large production...
EGFR Inhibitor AZD 3759;AZD3759;AZD-3759 CAS 1626387-80-1
AZD 3759 CAS 1626387-80-1, also called AZD3759 and AZD-3759, is oral, potent and brain-penetrant, EGFR tyrosine kinase inhibitor with potential antineoplastic activity. AZD 3759 CAS NO 1626387-80-1 is off-white powder with the purity by HPLC more than 99%. Backed by professional team, we are able to offer mass...
Mereletinib Mesylate AZD9291,AZD-9291 (Mesylate) 1421373-66-1
Mereletinib mesylate cas number 1421373-66-1 is the third generation of oral, irreversible selective EGFR mutant inhibitors that can be used for activated and resistant mutations in EGFR. For patients with advanced non-small cell lung cancer, 50% of the anti-EGFR treatment acquired resistance is caused by the T790M...
Potent VEGFR2 Inhibitor of Vandetanib CAS 443913-73-3
Vandetanib CAS NUMBER is 443913-73-3 is a multi-target tyrosine kinase inhibitor, belongs to aniline quinazoline compounds, as known as "second generation IRESSA". It is the first approved mediastinal thyroid cancer treatment drug that is suitable for the treatment of unresectable, locally advanced or metastatic...
EGFR Inhibitor AZD3759 Free Base 1626387-80-1
AZD3759 free base cas number is 1626387-80-1, Molecular formula: C22H24Cl2FN5O3,Molecular weight: 496.36, It is a white or almost white powder. Non-small cell lung cancer is one of the diseases which is a major threat to human health, More serious is up to 50% of this cancer patients in their lifetime will occur in...
AZD3759 Hydrochloride 1626387-81-2
AZD3759 hydrochloride 1626387-81-2 has the Molecular formula of C22H24Cl2FN5O3,Molecular weight of 496.36, it appearance is white or almost white powder. The Hplc of AZD3759 has purity ≥ 99.0%, single impurity ≤ 0.1%, enantiomeric ≤ 0.1%. We are normally keep stock of this product, we have sufficient stock to meet the...
EGFR Inhbitor EAI045;EAI 045;EAI-045 CAS 1942114-09-1
EAI045 1942114-09-1 is a new ectopic inhibitor for anti-epidermal growth factor receptor (EGFR) resistance mutation of lung cancer, it belongs to the fourth generation of new drugs. EAI045 is the first to overcome the T790M / C797S resistance mutation in the world . Our EAI045 purity Not less than 99% and have the...
CAS 928326-83-4,Vargatef Base or BIBF-1120,BIBF 1120,BIBF1120
Nintedanib referred to as Vargatef Base or BIBF-1120,BIBF 1120,BIBF1120, CAS number is 928326-83-4. It is an anti-tumor drug. In the treatment of idiopathic pulmonary fibrosis (IPF) worthy of our expectations. IPF is a fatal lung disease that is severely endangered by humans, with a median survival after diagnosis of...
AP26113;AP-26113 (Brigatinib) CAS 1197953-54-0
Brigatinib CAS number 1197953-54-0 referred to as AP26113, it is an inhibitor of lung cancer ALK target, is a non-small cell lung cancer targeted drugs. AP26113 is generally used after Crizotinib resistance, so in 2014 year the FDA awarded its tyrosine kinase inhibitor drug AP26113 orphan drug qualification for the...
Mereletinib For Advanced Non-small Cell Lung Cancer CAS 1421373-65-0
Mereletinib or Osimertinib (AZD-9291) CAS number is 1421373-65-0 which is a drug for the treatment of advanced non-small cell lung cancer, FDA expedited the approval process and approved the listing on 13th,November, 2015 . It is a kind of epidermal growth factor receptor (EGFR) kinase inhibitor, by inhibiting...
Categories
High Quality Products
Send Us a Message
We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.